From: Case reports: novel TUBG1 mutations with milder neurodevelopmental presentations
ID | Patient A | Patient B | Patient 11,3 | Patient 21,3 | Patient 31,3 | Patient 44 | Patient 54 | Patient 64 | Patient 74 | Patient 84 | Patient 94 | Patient 104 | Patient 114 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mutation | c.202G > A; p.Asp68Asn | c1021C > T; p.Arg341Trp | c.1160 T > C; p.Leu387Pro | c.275A > G; p.Tyr92Cys | c.991A > C; p.Thr331Pro | c.63C > A; p.Phe21Leu | c.985G > T; p.Asp329Tyr | c.776C > T; p.Ser259Leu | c.776C > T; p.Ser259Leu | c.776C > T; p.Ser259Leu | c.776C > T; p.Ser259Leu | c.769A > T; p.Ile257Phe | c.776C > T; p.Ser259Leu |
Mode of inheritance | De novo | De novo | De novo | De novo | Father’s DNA N/A | De novo | Father’s DNA N/A | De novo | De novo | Germline mosaicism in parent | Germline mosaicism in parent | De novo | De novo |
Mutation effect | Aspartate to asparagine within a highly conserved residue in the GTP-binding pocket | Arginine to tryptophan within a highly conserved residue located in the C-terminal domain that is required for the dimerization of y-tubulin | Leucine to proline within a highly conserved residue within an α-helix located in the C-terminal domain | Tyrosine to cysteine within a highly conserved residue in the vicinity of the GTPase domain | Threonine to proline within a highly conserved residue in an α-helix within the γ-γ protein interaction domain located in the C-terminal domain | Phenylalanine to leucine within the GTPase domain | Aspartate to tyrosine within a highly conserved residue in the C-terminal domain. Located on the surface of the TUBG1 protein | Serine to leucine within a highly conserved residue located in the C-terminal domain | Serine to leucine within a highly conserved residue located in the C-terminal domain | Serine to leucine within a highly conserved residue located in the C-terminal domain | Serine to leucine within a highly conserved residue located in the C-terminal domain | Isoleucine to phenylalanine within a highly conserved residue located in the C-terminal domain | Serine to leucine within a highly conserved residue located in the C-terminal domain |
Sex | F | M | F | M | F | M | M | F | F | F | M | M | F |
Age at follow-up | 10y | 6mo | 21y | 18mo | 31y | 33y | 21y | 19mo | 14y | 11y 6mo | 9y 6mo | 15y | 18mo |
Head circumference | <−2.1 SD | <−1.9 SD | <−5.5 SD | <−4 SD | <−1 SD | 57 cm | 53.1 cm (<−2.6 SD) | <−3.5 SD | N/A | 47.5 cm at 6y 6mo (<−3.3 SD) | N/A | 51.3 cm at 13y (<− 2.5 SD) | N/A |
Epileptic | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes |
Seizure age of onset | – | < 1 h of life | Early-onset | N/A | Early-onset | 36mo | N/A | – | 6mo | 4mo | N/A | 3y 11mo | 5mo |
Type of seizures | – | Focal with secondary bilateral synchrony | N/A | Infantile spasms | N/A | Tonic-atonic-myoclonic | Partial complex; versive, myoclonic | – | Tonic-clonic | Generalized tonic-clonic | N/A | N/A | Focal, versive |
Refractory epilepsy | – | No | Yes | Yes | Yes | N/A | Yes | – | N/A | N/A | N/A | N/A | No |
Motor dysfunction | No | Mild axial hypotonia; appendicular hypertonia | Spastic tetraplegia (bedridden) | Spastic tetraplegia (bedridden) | Moderate cerebral palsy | Spastic tetraplegia (walks with support) | Spastic tetraplegia | Delayed motor development | Unsteady gait | Spastic diplegia | N/A | N/A | Delayed motor development |
ID | Moderate | Moderate global delay | Severe | Severe | Moderate | Severe | Severe | N/A | N/A | Moderate | Moderate | Moderate (FS IQ-score 44) | Severe |
Speech and Language Development | Normal | Moderate global delay | N/A | N/A | N/A | Only sounds, no speech | Non-verbal | Delayed | Non-verbal | 50 words | Non-verbal | 5–6 word sentences | Non-verbal |
Age at MRI | 9y | 13 days | N/A | N/A | N/A | 36y | 11y | 1y 6mo | 12mo | 13y 7mo | 2mo | 6y | 9y |
Cortical dysgenesis (MRI) | Posterior predominant pachygyria, band heterotopia, nodular heterotopia | Reduced cortical sulci and gyri | Severe posterior predominant pachygyria/agyria (posterior agyria, frontal pachygyria), thick cortex | Severe posterior predominant pachygyria/agyria (posterior agyria, frontal pachygyria), thick cortex | Posterior pachygyria, moderate posterior subcortical band heterotopia | Posterior predominant pachygyria (posterior frontal lobe and parieto-occipital cortex) | Diffuse agyria | Posterior predominant pachygyria (mild over frontal lobes, moderate over posterior lobes), cortex 10-13 mm thick | Posterior predominant pachygyria, sparse cells over occipital lobes, cortex 13-15 mm thick | Posterior predominant pachygyria (mild over frontal lobe, moderate over temporal and occipital lobes), cortex 6-13 mm thick | Posterior predominant pachygyria (mild over frontal lobe, moderate over temporal and occipital lobes), cortex > 15 mm thick | Posterior predominant pachygyria (almost normal over frontal lobes, pachygyria over perisylvian and occipital lobes), cortex 6-10 mm thick | Posterior predominant pachygyria (mild over frontal lobe, moderate over temporal and occipital lobe, deep parietal lobe infolding) |
Corpus callosum (MRI) | Normal-Thick | Normal | Thin | Thick, dysmorphic | Thick, dysmorphic | Normal | Thin | Normal | Normal | Normal | Thin | Normal | Thin |
Other MRI Findings | – | General paucity of white matter, small cerebellum, dilated lateral ventricles, small lentiform nuclei, small thalami, posterior limbs of internal capsule lacking myelination | Mildly enlarged lateral ventricles, mildly reduced white matter | Mildly enlarged lateral ventricles, severely reduced white matter | – | Enlarged perivascular spaces, enlarged posterior horns of lateral ventricles, hippocampal malrotation | Severely enlarged lateral ventricles, severely reduced white matter, dysplastic basal ganglia, hypoplastic brainstem, hypoplastic vermis | Mildly enlarged lateral ventricles, mildly reduced white matter | Mildly enlarged lateral ventricles, mildly reduced white matter | Enlarged posterior horns of lateral ventricles | Mildly enlarged lateral ventricles | Mildly enlarged posterior horns of lateral ventricles, mildly reduced white matter | Mildly enlarged lateral ventricles, mildly reduced white matter, dysplastic basal ganglia |